Covance Inc. Invites You to Join the Webcast of Its Second Quarter 2008 Financial Results Conference Call

PRINCETON, N.J., July 1 In conjunction with itssecond quarter 2008 earnings release, Covance Inc. (NYSE: CVD) is pleased toinvite you to listen to its quarterly investor conference call that will bebroadcast live over the Internet on Thursday, July 31, 2008 at 9:00 a.m. ET.

Covance, with headquarters in Princeton, New Jersey, is one of the world'slargest and most comprehensive drug development services companies with annualrevenues greater than $1.5 billion, global operations in more than 20countries, and more than 8,900 employees worldwide. Information on Covance'sproducts and services, recent press releases, and SEC filings can be obtainedthrough its website at www.covance.com.

*If you are unable to participate during the live webcast, the event willbe archived on the web site http://www.covance.com for 14 days.What: Covance Second Quarter 2008 Earnings Webcast and Slide Presentation When: July 31, 2008, 9:00 a.m. ET* Where: http://www.covance.com

SOURCE Covance Inc.

Latest Press Release on General News

Brains Bioceutical Announces the Addition of Industry Veteran John Boshart to its Animal Health Division

VANCOUVER, British Columbia, May 06, 2024 (GLOBE NEWSWIRE) -- Today marks a pivotal development for Brains Bioceutical Corp ("Brains Bio"), as it significantly strengthens its Veterin...

Nicklaus Children's Health System, Philips to Provide Innovative Patient and Staff Experience, Helping to Enhance Outcomes for the Smallest of Patients

April 30, 2024 Philips AI-enabled diagnostic and experiential technologies help put patients at ease while empowering staff with faster, high-quality scans and increased diagnostic c...

Cinesteam® Is a Deodorizing Support Tool for Palliative Care

Palliative Care Is a Comprehensive Approach to Long-Term Patient Care. Caregivers Can Use Cinesteam®'s Secondary Dressings to Improve Quality of Life in Palliative Care Settings. FOR...

Philips Delivers First-quarter Results in Line With 2024 Performance Improvement Plan; Resolves the Respironics Personal Injury and Medical Monitoring Litigation in the Us for USD 1.1 Billion

April 29, 2024 First-quarter highlights Group sales amounted to EUR 4.1 billion, with comparable sales growth of 2.4% Comparable order intake -3.8%, mainly due to China USD 1.1 b...

eNeura Achieves Record-Breaking Sales and Announces Notice of Allowance for a New Patent on Prophylactic Treatment of Migraine Headache

Record sales in April accelerating the pathway to profitability New IP will lead the way in changing the way migraine headaches are addressed WEST PALM BEACH, Fla. , April 26, ...